The Current Ratio as of November 2024 (TTM) for Adicet Bio, Inc. (ACET) is 10.64

According to Adicet Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.64. This represents a change of -7.78% compared to the average of 11.54 of the last 4 quarters.

Adicet Bio, Inc. (ACET) Historical Current Ratio (quarterly & annually)

How has ACET Current Ratio performed in the past?

The mean historical Current Ratio of Adicet Bio, Inc. over the last ten years is 8.75. The current 10.64 Current Ratio has changed 12.06% with respect to the historical average. Over the past ten years (40 quarters), ACET's Current Ratio was at its highest in in the March 2022 quarter at 27.07. The Current Ratio was at its lowest in in the March 2017 quarter at 2.07.

Adicet Bio, Inc. (ACET) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Adicet Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adicet Bio, Inc. (ACET) Average Current Ratio

How has ACET Current Ratio performed in the past?

The current Current Ratio of Adicet Bio, Inc. (ACET) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Adicet Bio, Inc. (ACET) Current Ratio vs. Peers

How is ACET’s Current Ratio compared to its peers?

Adicet Bio, Inc.’s Current Ratio is less than Edgewise Therapeutics, Inc. (26.35), less than Talaris Therapeutics, Inc. (18.64), less than Cullinan Oncology, Inc. (24.46), greater than Vor Biopharma Inc. (4.69), greater than Tenaya Therapeutics, Inc. (5.27), less than Bicycle Therapeutics plc (17.13), greater than IGM Biosciences, Inc. (5.22), greater than Monte Rosa Therapeutics, Inc. (6.03), greater than Stoke Therapeutics, Inc. (5.09), greater than Aerovate Therapeutics, Inc. (8.78), less than Acrivon Therapeutics, Inc. Common Stock (12.75), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Agios Pharmaceuticals, Inc. (8.99), greater than Homology Medicines, Inc. (4.19), less than Nkarta, Inc. (12.91), greater than Pliant Therapeutics, Inc. (10.26), greater than Alector, Inc. (3.29), greater than Aadi Bioscience, Inc. (4.89), less than Keros Therapeutics, Inc. (19.03),

Build a custom stock screener for Adicet Bio, Inc. (ACET) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adicet Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adicet Bio, Inc. (ACET) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adicet Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.